KPTI Dividend: Karyopharm Therapeutics Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	142	145	146	157	209	108
Revenue Growth (YoY)	-4%	-1%	-7%	-25%	94%	170%
Cost of Revenue	5	6	4	5	3	2
Gross Profit	136	139	141	151	206	105
Selling, General & Admin	109	115	131	145	143	126
Research & Development	131	143	138	148	160	150
Operating Expenses	240	258	270	294	304	277
Other Non Operating Income (Expenses)	20	28	0	0	0	0
Pretax Income	-124	-76	-142	-164	-123	-196
Income Tax Expense	0	0	0	0	0	0
Net Income	-124	-76	-143	-165	-124	-196
Net Income Growth	43%	-47%	-13%	33%	-37%	-2%
Shares Outstanding (Diluted)	8.66	8.12	7.61	5.45	5.01	4.8
Shares Change (YoY)	4%	7%	40%	9%	4%	16%
EPS (Diluted)	-14.37	-9.4	-18.79	-30.28	-24.74	-40.86
EPS Growth	37%	-50%	-38%	22%	-39%	-15%
Free Cash Flow	-89	-127	-92	-149	-107	-160
Free Cash Flow Per Share	-10.26	-15.63	-12.08	-27.29	-21.33	-33.31
Gross Margin	95.77%	95.86%	96.57%	96.17%	98.56%	97.22%
Operating Margin	-73.23%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
Profit Margin	-87.32%	-52.41%	-97.94%	-105.09%	-59.33%	-181.48%
Free Cash Flow Margin	-62.67%	-87.58%	-63.01%	-94.9%	-51.19%	-148.14%
EBITDA	-104	-119	-129	-142	-98	-171
EBITDA Margin	-73.23%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-104	-119	-129	-142	-98	-171
EBIT Margin	-73.23%	-82.06%	-88.35%	-90.44%	-46.88%	-158.33%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Karyopharm Therapeutics Inc (KPTI) Price